| dc.creator | Payá G,Ernesto | |
| dc.creator | Alvarez P,Ana María | |
| dc.creator | Avilés L,Carmen | |
| dc.creator | Cofré G,José | |
| dc.creator | Enríquez O,Nancy | |
| dc.creator | Salgado M,Carmen | |
| dc.creator | Santolaya de P,María Elena | |
| dc.creator | Silva G,Pamela | |
| dc.creator | Tordecilla C,Juan | |
| dc.creator | Varas P,Mónica | |
| dc.creator | Villarroel C,Milena | |
| dc.creator | Zubieta A,Marcela | |
| dc.date | 2001-11-01 | |
| dc.date.accessioned | 2020-02-17T15:27:27Z | |
| dc.date.available | 2020-02-17T15:27:27Z | |
| dc.identifier | https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872001001100009 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/127374 | |
| dc.description | Background: Pediatric patients in treatment for cancer can have fatal bacterial infections. Thus, in the presence of fever or other signs infection, antimicrobials have to be prescribed empirically. Aim: To know the causative agents of bacteremia in children with cancer, their changes with time and between different hospitals and their patterns of susceptibility. Material and methods: We reviewed the blood cultores of children with cancer in five hospitals of Santiago, from 1994 at 1998. Results: During the study period, 707 agents were isolated. The most frequently isolated species or genus were coagulase negative Staphylococcus (43%), Staphylococcus aureus (16%), Escherichia coli (9%), Klebsiella spp. (8%), Pseudomonas spp. (5%) and Candida spp. (4%). Coagulase negative Staphylococcus was 55% resistant to meticilin and S. aureus was 44% resistant. Enterobacteriae had 15% resistance to gentamicin and amikacin, 2% to imipenem, 26% to ceftriaxone, 21% to cefotaxim and 20% to ceftazidim. Among non fermenting agents resistance was 6% for imipenem, 9% for amikacin 10% for ciprofloxacin, 19% for ceftazidim and 22% for cefoperazone. The resistance of Streptococcus spp. (non pneumoniae) to penicillin reached 50% and that of Enterococcus spp. was of 33%. Conclusions: Treatment for pediatric patients with cancer must be modified and new guidelines including more active medications for patients at risk for bacteremia, should be devised (Rev Méd Chile 2001; 129: 1297-1304) | |
| dc.format | text/html | |
| dc.language | es | |
| dc.publisher | Sociedad Médica de Santiago | |
| dc.relation | 10.4067/S0034-98872001001100009 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | Revista médica de Chile v.129 n.11 2001 | |
| dc.subject | Bacteremia | |
| dc.subject | Bacterial infections | |
| dc.subject | Infection control, Neoplasms | |
| dc.title | Agentes causantes de infecciones del torrente circulatorio en niños con cáncer, en cinco hospitales de Santiago (1994-1998) | |
